Methodology
Read the full methodology
Weekly index level since May 17, 2026. Constituents are cap-weighted with the divisor reset on each monthly rebalance.
Every atom in the index, cap-weighted with confidence adjustment. Click a row to drill into the underlying card detail. 20 of 283 shown.
| Umbreon δ Umbreon - Reverse Holo | PSA9 | 5.3% | $479.9K | 77 | 0.1% |
| Espeon δ Espeon - Reverse Holo | PSA10 | 4.5% | $404.2K | 65 | 0.2% |
| Rayquaza δ Rayquaza - Reverse Holo | PSA10 | 4.5% | $400.9K | 38 | 0.0% |
| Rayquaza δ Rayquaza - Reverse Holo | PSA9 | 4.2% | $379.0K | 76 | 1.9% |
| Latias δ Latias - Reverse Holo | PSA10 | 3.5% | $310.4K | 83 | 0.2% |
| Salamence δ Salamence - Reverse Holo | PSA10 | 3.4% | $306.5K | 67 | 0.1% |
| Umbreon δ Umbreon - Reverse Holo | PSA10 | 3.0% | $272.6K | 33 | 0.0% |
| Jolteon δ Jolteon - Reverse Holo | PSA10 | 3.0% | $267.1K | 71 | 0.0% |
| Mewtwo δ Mewtwo - Reverse Holo | PSA9 | 2.9% | $260.0K | 70 | 0.2% |
| Vaporeon δ Vaporeon - Reverse Holo | PSA10 | 2.7% | $243.0K | 57 | 0.9% |
| Umbreon δ Umbreon - Reverse Holo | PSA8 | 2.6% | $234.1K | 82 | 0.1% |
| Dragonite δ Dragonite - Reverse Holo | PSA10 | 2.4% | $215.9K | 39 | 0.0% |
| Mewtwo δ Mewtwo - Reverse Holo | PSA8 | 2.1% | $187.8K | 70 | 0.1% |
| Ditto [Pikachu] - Reverse Holo | PSA9 | 2.0% | $181.9K | 71 | 0.8% |
| Flareon δ Flareon - Reverse Holo | PSA10 | 1.8% | $164.9K | 47 | 0.0% |
| Tyranitar δ Tyranitar - Reverse Holo | PSA9 | 1.7% | $155.5K | 61 | 0.0% |
| Rayquaza δ Rayquaza - Reverse Holo | PSA8 | 1.7% | $154.4K | 77 | 2.9% |
| Latios δ Latios - Reverse Holo | PSA9 | 1.6% | $146.3K | 77 | 3.0% |
| Vaporeon δ Vaporeon - Reverse Holo | PSA9 | 1.6% | $140.6K | 67 | 0.7% |
| Espeon δ Espeon - Reverse Holo | PSA8 | 1.5% | $138.1K | 66 | 0.0% |
Most recent weekly rebalance events. The divisor is reset on each event so the index level remains continuous through composition changes; subsequent moves are price-driven.
Read the full methodology
Other indices that share this print run or this grade tier, plus the parent set.